Why Medicines Can Modify Physical Performance

Athletic performance is not produced by muscle alone. It emerges from a network in which the brain, autonomic nervous system, heart, blood, lungs, metabolism, endocrine system, sleep and pain perception operate together. Medicines can intervene in almost every one of these components. In elite sport, a seemingly small change in one link can alter the final result.

This is the territory of performance pharmacology: understanding how medicines and other pharmacologically active substances can modify a physiological function relevant to exercise. Some have legitimate therapeutic roles, some influence performance without that being the primary purpose of treatment, and some are misused for an advantage. Those situations must be distinguished carefully.

1. Performance Is a System, Not a Single Number

An athlete may perform better because they produce more force, sustain a higher intensity, tolerate fatigue better, breathe more efficiently, perceive effort differently or recover faster. A medicine does not need to increase muscle force directly to change the final result. Altering alertness or perceived exertion, for example, can change how much effort an athlete is willing to sustain.

2. Where Pharmacology Can Intervene

Pharmacological substances can modify central nervous system activity, contractility and heart rate, plasma volume, oxygen transport, glucose and lipid metabolism, inflammation, pain, sleep or endocrine function. The sporting effect is often secondary to the primary medical effect. This matters because not every performance change is pharmacologically intentional.

3. Stimulation Is Not the Same as Adaptation

A stimulant may increase alertness or reduce perceived fatigue, but that does not mean tissues have instantly become more resilient. You may continue producing effort while warning signals are being altered. The difference between tolerating more and being physiologically better adapted is a central idea of this series.

4. Why Perceived Exertion Matters

The brain integrates information about temperature, heart rate, breathlessness, pain and fatigue. Changing these signals can alter sporting behavior even if underlying physiology has not improved proportionally. A better result in a single event therefore does not automatically mean every body system is functioning better.

5. A Medicine Can Also Change the Price the Body Pays

An apparent performance increase may come with costs: higher blood pressure, tachycardia, arrhythmias, hyperthermia, dehydration, sleep disruption, metabolic changes or masking of injury. Performance pharmacology therefore has to be studied together with risk pharmacology. A favorable effect in one event can have an unfavorable balance when the longer term is considered.

6. Why Some Medicines Enter Sport

There are three main situations: treatment of illness in an athlete, off-label or non-medical use for a possible advantage, and deliberate use of a substance prohibited by anti-doping rules. These situations should not be conflated. An athlete can be a patient and a competitor at the same time, while medical status and anti-doping status are separate questions.

7. How Pharmacological Advantage Appears

An advantage may come from increased energy availability, nervous-system stimulation, altered oxygen transport, reduction of a physiological limitation, or a changed response to pain and fatigue. Sometimes the effect is direct on performance; sometimes it is indirect. In a strength sport, regulation of activation and tolerance of effort may matter as much as any direct change in contractility.

8. Why the Same Medicine Can Help and Harm

Pharmacology is not an equation in which more effect automatically means more performance. Therapeutic exposure, excessive exposure and drug combinations can produce very different profiles. Dose-response relationships, therapeutic windows and interactions matter, especially when the body is already under high physiological stress.

9. Performance Is Not the Same as Health

An athlete can obtain a better result despite worse functioning in some systems. That makes pharmacological assessment difficult: immediate success does not prove long-term safety. Medical analysis must separate competitive outcome, physiological state and cumulative consequences.

10. The Stimulant Example

Research on stimulant medicines shows that some can alter physical performance and perceived exertion, but they can also raise heart rate and core temperature. These effects illustrate the difference between performance obtained and physiology safely improved. Later episodes will examine stimulants in detail.

11. The Sleep Example

A medicine that changes sleep can indirectly influence performance. If sleep deteriorates, attention, strength, recovery and injury risk can all be affected. That is why performance pharmacology also includes recovery pharmacology and cannot be reduced to what happens during a single training session.

12. The Athlete as a Patient Is a Special Case

Athletes have unusually high physiological demands. A side effect that is modest in the general population may become important when heart rate, temperature, dehydration, mechanical stress and metabolic demand are already elevated. Athletes may also interpret drug effects through the lens of competition rather than health.

13. Interactions Can Completely Change the Picture

Two or more substances can have additive or opposing effects. A stimulant combined with dehydration, an analgesic combined with injury, or several medicines sharing a metabolic pathway can create a risk profile different from that of each substance alone. A complete medication and supplement history is therefore essential.

14. What Evidence-Based Pharmacology Means

It means separating biological mechanism, observed study effect, real-world sporting relevance and risk. A substance may have a plausible mechanism without a demonstrated competitive advantage. Study quality, population and event context also matter, because laboratory findings do not automatically transfer to an elite strongman or another high-level athlete.

15. Anti-Doping Regulation

The 2026 WADA Prohibited List includes classes such as anabolic agents, peptide hormones and growth factors, hormone and metabolic modulators, diuretics and masking agents, stimulants, narcotics, cannabinoids, glucocorticoids and beta-blockers. Some are prohibited at all times, others only in-competition, and certain substances have specific conditions. Anti-doping status must be checked separately from medical indication.

16. Conclusion

Performance pharmacology is not a list of pills for better results. It is the study of how pharmacological interventions can modify systems that limit or support performance and, at the same time, the biological costs that may follow. This series will follow each of these entry points, from the nervous system and oxygen transport to metabolism, pain, sleep and interactions.

Key Scientific Sources

World Anti-Doping Agency. 2026 Prohibited List.
Performance-Enhancing Drugs in Healthy Athletes: An Umbrella Review of Systematic Reviews and Meta-analyses.
Medical literature on stimulant pharmacology, sleep, analgesia and the physiology of athletic performance.

Editorial note: this article is educational and does not provide doses, cycles, combinations or recommendations for performance-enhancing use.